SFX by Ex Libris Inc.

Title:	Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc
Source:	Glycobiology [0959-6658] Dricu, Anica yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Werner, N. "Pleiotropic effects of HMG-CoA reductase inhibitors." Basic research in cardiology 97.2 (2002): 105-16.
description	2.	Carlberg, M. "Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth." The Journal of biological chemistry 271.29 (1996): 17453-62.
description	3.	Jaffer, F. "Statin therapy reduces cysteine protease activity in atherosclerosis in vivo." Circulation 114.18 (2006): 337-337.
description	4.	Almuti, K. "Effects of statins beyond lipid lowering: potential for clinical benefits." International Journal of Cardiology 109.1 (2006): 7-15.
description	5.	März, W. "HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?" Herz 25.2 (2000): 117-125.
description	6.	Mössner, R. "Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma." The Journal of investigative dermatology 119.3 (2002): 576-82.
description	7.	Vega, G L L. "Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men." The American journal of cardiology 81.4A (1998): 36-42.
description	8.	Athyros, Vasilios G G. "Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study." Current medical research and opinion 18.4: 220-228.
description	9.	Kato, M. "Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits." Journal of cardiovascular pharmacology 46.4 (2005): 556-62.
description	10.	Placha, W. "The effect of PPAR[gamma] ligands on the proliferation and apoptosis of human melanoma cells." Melanoma research 13.5 (2003): 447-456.
description	11.	Liao, Adam K. "Pleiotropic Effects of Statins on the Cardiovascular System." Circulation research 120.1 (2017): 229-243.
description	12.	Bliwise, Dainis L. "Improvement in obstructive sleep apnea in the supine knees-up position." Sleep & breathing 8.1 (2004): 43-47.
description	13.	Jormsjo, S. "Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice." The American journal of pathology 161.3 (2002): 939-945.
description	14.	Peck, A. "Effect of statins on estrogen and androgen levels in postmenopausal women treated with estradiol." Climacteric 14.1 (2011): 49-53.
description	15.	Schellingerhout, Woo K. "Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine." Molecular imaging 8.5 (2009): 291-301.
description	16.	Trebicka, J. "Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells." Journal of Hepatology 53.4 (2010): 702-712.
description	17.	Panda, T. "Regulation and degradation of HMGCo-A reductase." Applied microbiology and biotechnology 66.2 (2004): 143-152.
description	18.	Senn, H J. "Concentration, pattern and transport by lipoproteins." European journal of biochemistry 181.3 (1989): 657-.
description	19.	Ginsberg, H N N. "Effects of statins on triglyceride metabolism." The American journal of cardiology 81.4A: 32-35.
description	20.	Arad, Y. "Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins." Metabolism, clinical and experimental 41.5 (1992): 487-93.